-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2015 to Q2 2024.
- Lineage Cell Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 189M shares, a 10.7% increase year-over-year.
- Lineage Cell Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 173M shares, a 1.69% increase from 2022.
- Lineage Cell Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 170M shares, a 3.22% increase from 2021.
- Lineage Cell Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 165M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)